Information  X 
Enter a valid email address

Honye Financial Svcs (HOYE)

  Print      Mail a friend

Wednesday 15 April, 2020

Honye Financial Svcs

Exercise of Warrants and Total Voting Rights

RNS Number : 7637J
Honye Financial Services Ltd
15 April 2020
 

Honye Financial Services Ltd

( " Honye" or the " Company")

 

Exercise of Warrants and Total Voting Rights

 

Honye Financial Services Ltd announces that it has received a warrant exercise notice over an aggregate total of 30,000 ordinary shares of £0.01 each ("Ordinary Shares") in the Company for total consideration of £4,500.

 

An application has been made for 30,000 Ordinary Shares to be admitted to the standard listing segment of the Official List of the Financial Conduct Authority and to be admitted to trading on the main market for listed securities of the London Stock Exchange plc (together, "Admission"). Admission is expected to become effective at 8.00 a.m. on 20 April 2020.

 

Total Voting Rights

 

On Admission, the Company's issued share capital will consist of 24,671,350 ordinary shares of £0.01 each. There are no ordinary shares held in treasury. Accordingly, the total number of voting rights in Honye at Admission will be 24,671,350.

 

The above figure 24,671,350 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Honye under the FCA's Disclosure Guidance and Transparency Rules.

 

 

The Directors accept responsibility for this announcement.

-END-

Enquiries:

 

Honye Financial Services Ltd
Gareth Edwards

[email protected]

 

Peterhouse Capital Limited (sole broker)

Lucy Williams/Heena Karani

Tel: 020 7469 0930

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
STRFLFELSVIELII

a d v e r t i s e m e n t